FMR1 and fragile X syndrome: Accordingly, in the last few years, neurotransmission and synaptic deficits have been shown in the Fmr1 knockout (KO) mouse models, which show common phenotypes with FXS patients, opening new potential targets for therapeutic interventions (4, 9).